ITF Therapeutics-Givinostat Registry

ITF Therapeutics-Givinostat Registry

Es posible que algunos contenidos no estén disponibles en español.

Who Can Participate?

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

A Prospective, Observational Study Evaluating the Real-World Experience of Givinostat in Patients with Duchenne Muscular Dystrophy

Principal Investigator

Natalie
Katz

Protocol Number

PRO00119323

NCT ID

NCT07127978

Phase

N/A

Enrollment Status

Open to Enrollment